Churg J, Habib R, White RHR: A report of the international study of kidney disease in children: Pathology of the nephrotic syndrome in childhood . Lancet 1:1299-1302, 1970;.
White RHR, Glasgow EF, Mills RJ: Clinicopathologic study of nephrotic syndrome in childhood . Lancet 1:1353-1359, 1970;.
Habib R: Focal glomerular sclerosis . Kidney Int 4:355-361, 1973;.
Siegel NJ, Kashgarian M, Spargo BH, et al: Minimal change and focal sclerotic lesions in lipoid nephrosis . Nephron 13:125-137, 1974;.
Habib R, Kleinknecht C, Gubler M-C: Extramembranous glomerulonephritis in children: Report of 50 cases . J Pediatr 82:754-766, 1973;.
Berlyne GM, Mallick NP: Ischaemic heart-disease as a complication of nephrotic syndrome . Lancet 1:399-400, 1969;.
Alexander JH, Schapel GJ, Edwards KDG: Increased incidence of coronary heart disease associated with combined elevation of serum triglyceride and cholesterol concentrations in the nephrotic syndrome in man . Med J Aust 2:119-122, 1974;.
Stern MP, Kolterman OG, Fries JF, et al: Adrenocortical steroid treatment of rheumatic diseases . Arch Intern Med 132:97-101, 1973;.
Bagdade JD, Porte D Jr, Bierman EL: Hypertriglyceridemia: A metabolic consequence of chronic renal failure . N Engl J Med 279:181-185, 1968;.
Ibels LS, Simons LA, King JO, et al: Studies on the nature and causes of hyperlipidemia in uraemia, maintenance dialysis and renal transplantation . Q J Med 44:601-614, 1975;.
Kannel WB, Dawber TR: Atherosclerosis as a pediatric problem . J Pediatr 80:544-554, 1972;.
Schwarz H, Kohn JL: Lipoid nephrosis: A clinical and pathologic study based on 15 years' observation with special reference of prognosis . Am J Dis Child 49:579-593, 1935;.
Gofman JW, Jones HB, Lindgren FT, et al: Blood lipids and human atherosclerosis . Circulation 2:161-178, 1950;.
Berlyne GM, Tavill AS, Baker SBD: Renal artery stenosis and the nephrotic syndrome . Q J Med 33:325-335, 1964;.
Kallen RJ, Lee S-K, Aronson AJ, et al: Idiopathic membranous glomerulopathy preceeding the emergence of systemic lupus erythematosus in two children . J Pediatr 90:72-76, 1977;.
Matsuda I: Incidence of atherosclerosis in nephrosis . J Pediatr 67:152, 1965;.
Fredrickson DS, Levy RI, Lees RS: Medical progress: Fat transport in lipoproteins—an integrated approach to mechanisms and disorders . N Engl J Med 276:32-44, 94-103, 148-156, 215-226, 273-281, 1967;.
Baxter JH, Goodman HC, Havel RJ: Serum lipid and lipoprotein alterations in nephrosis . J Clin Invest 39:455-465, 1960;.
Chopra JS, Mallick NP: Hyperlipoproteinaemias in nephrotic syndrome . Lancet 1:317-321, 1971;.
Newmark SR, Anderson CF, Donadio JV, et al: Lipoprotein profiles in adult nephrotics . Mayo Clinic Proc 50:359-364, 1975;.
Slack J: Risks of ischaemic heart-disease in familial hyperlipoproteinaemic states . Lancet 2:1380-1382, 1969;.
Glueck CJ, Fallat RW, Tsang R, et al: Hyperlipemia in progeny of parents with myocardial infarction before age 50 . Am J Dis Child 127:70-75, 1974;.
Council on Foods and Nutrition: Diet and coronary heart disease: A council statement . JAMA 222:1647, 1972;.
Kannel WB, Castelli WP, Gordon T, et al: Serum cholesterol, lipoproteins, and the risk of coronary heart disease: The Framingham study . Ann Intern Med 74:1-12, 1971;.
International Study of Kidney Disease in Children: Prospective, controlled trial of cyclophosphamide therapy in children with the nephrotic syndrome . Lancet 2:423-427, 1974;.
Siegel NJ, Goldberg B, Krassner LS, et al: Long-term follow-up of children with steroid-responsive nephrotic syndrome . J Pediatr 81:251-258, 1972;.
Schwartz MW, Schwartz GJ, Cornfeld D: A 16-year follow-up study of 163 children with nephrotic syndrome . Pediatrics 54:547-552, 1974;.
Lindner A, Charra B, Sherrard DJ: Accelerated atherosclerosis in prolonged maintenance hemodialysis . N Engl J Med 290:697-701, 1974;.
Pennisi AJ, Fiedler J, Lipsey A, et al: Hyperlipidemia in pediatric renal allograft recipients . J Pediatr 87:249-251, 1975;.
Ibels LS, Stewart JH, Mahony JF, et al: Deaths from occlusive arterial disease in renal allograft recipients . Br Med J 3:552-554, 1974;.
Lees RS, Wilson DE: Medical Progress—The treatment of hyperlipidemia . N Engl J Med 284:186-195, 1971;.
National Institutes of Health Conference: Dietary and drug treatment of primary hyperlipoproteinemia . Ann Intern Med 77:267-294, 1972;.
Bridgman JF, Rosen SM, Thorp JM: Complications during clofibrate treatment of nephrotic-syndrome hyperlipoproteinaemia . Lancet 1:506-509, 1972;.
Fabre J, Denizot M, Micheli H, et al: Correction of hyperlipemia of the nephrotic syndrome by clofibrate: Muscular side-effect of the drug , abstract ed. Kidney Int 3:273, 1973;.
Larsen R, Glueck CJ, Tsang R: Special diet for familial type II hyperlipoproteinemia . Am J Dis Child 128:67-72, 1974;.